1.
Cardiovascular Toxicity of Nicotine: Implications for Electronic Cigarette Use
by Benowitz, Neal L
Trends in cardiovascular medicine, 2016, Vol.26 (6), p.515-523
2.
Cardiac and vascular effects of fingolimod: Mechanistic basis and clinical implications
by Camm, John, MD
The American heart journal, 2014, Vol.168 (5), p.632-644
3.
The neprilysin pathway in heart failure: a review and guide on the use of sacubitril/valsartan
by Jhund, Pardeep S
Heart (British Cardiac Society), 2016, Vol.102 (17), p.1342-1347
4.
Angiotensin-Converting Enzyme 2 Metabolizes and Partially Inactivates Pyr-Apelin-13 and Apelin-17: Physiological Effects in the Cardiovascular System
by Wang, Wang
Hypertension (Dallas, Tex. 1979), 2016, Vol.68 (2), p.365-377
5.
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and...
by Willhite, Calvin C
Critical reviews in toxicology, 2014, Vol.44 (S4), p.1-80
6.
Antioxidants in Cardiovascular Health and Disease: Key Lessons from Epidemiologic Studies
by Willcox, Bradley J., MD
The American journal of cardiology, 2008, Vol.101 (10), p.S75-S86
7.
The Mechanisms Underlying Lipid Resuscitation Therapy
by Fettiplace, Michael R
Regional anesthesia and pain medicine, 2018, Vol.43 (2), p.138-149
8.
FDA labeling of NSAIDs: Review of nonsteroidal anti-inflammatory drugs in cardiovascular disease
by Pirlamarla, Preethi, MD
Trends in cardiovascular medicine, 2016, Vol.26 (8), p.675-680
9.
The Effect of Testosterone on Cardiovascular Biomarkers in the Testosterone Trials
by Mohler, Emile R. Emile R.
The journal of clinical endocrinology and metabolism, 2017, Vol.103 (2), p.681-688
10.
Review of Published Cases of Adverse Cardiovascular Events After Ingestion of Energy Drinks
by Goldfarb, Michael, MD
The American journal of cardiology, 2014, Vol.113 (1), p.168-172
11.
Cardiovascular effects of caffeinated beverages
by Voskoboinik, Aleksandr
Trends in cardiovascular medicine, 2019, Vol.29 (6), p.345-350
12.
Management of cardiac toxicity in patients receiving vascular endothelial growth factor signaling pathway inhibitors
by Steingart, Richard M., MD
The American heart journal, 2012, Vol.163 (2), p.156-163
13.
Sesquiterpene lactones: Adverse health effects and toxicity mechanisms
by Amorim, M. Helena R
Critical reviews in toxicology, 2013, Vol.43 (7), p.559-579
14.
Preeclampsia and the cardiovascular system: An update
by Perry, Helen
Trends in cardiovascular medicine, 2018, Vol.28 (8), p.505-513
15.
Association of Central and Peripheral Blood Pressures With Intermediate Cardiovascular Phenotypes
by ROMAN, Mary J
Hypertension (Dallas, Tex. 1979), 2014, Vol.63 (6), p.1148-1153
16.
Cardiovascular Actions of Insulin
by Muniyappa, Ranganath
Endocrine reviews, 2007, Vol.28 (5), p.463-491
17.
Neonatal Oxygen Exposure in Rats Leads to Cardiovascular and Renal Alterations in Adulthood
by Yzydorczyk, Catherine
Hypertension (Dallas, Tex. 1979), 2008, Vol.52 (5), p.889-895
18.
The Cardiovascular Effects of GLP-1 Receptor Agonists
by Okerson, Theodore
Cardiovascular therapeutics, 2012, Vol.30 (3), p.e146-e155
19.
From particles to patients: oxidative stress and the cardiovascular effects of air pollution
by Miller, Mark R
Future cardiology, 2012, Vol.8 (4), p.577-602
20.
Dietary flavonoids and nitrate: effects on nitric oxide and vascular function
by Bondonno, Catherine P
Nutrition reviews, 2015, Vol.73 (4), p.216-235
